Showing items 1 - 11 of 11

Your selections:

Medicinal Cannabis Guidance and Resources for Health Professionals to Inform Clinical Decision Making

Cannabidiol drug interaction considerations for prescribers and pharmacists

NSW Cannabis Medicines Advisory Service preliminary survey results: enquirer perceptions and patient outcomes

Vancomycin therapeutic drug monitoring in paediatrics

Optimising low-dose methotrexate for rheumatoid arthritis—a review

Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects.

Exogenous cannabinoid efficacy: merely a pharmacokinetic interaction?

Laxative use in inpatients on oxycodone/naloxone prolonged release and oxycodone prolonged release for cancer and non-cancer pain

The pharmacokinetics and the pharmacodynamics of cannabinoids

Pharmacokinetic-guided dosing of new oral cancer agents

Predicting drug interactions in addiction treatment

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit